Indigo Blue is a modern hybrid-indica whose exact lineage remains undocumented. While its precise primary genetic origins are unknown, it serves as a significant genetic contributor in its own right, being the direct parent of the notable offspring Oxygen 19. Cultivators categorize this strain as one of moderate difficulty, capable of thriving in both indoor and outdoor environments. Growers seek it out due to its efficient 44-day flowering cycle and its capacity for high yields.

The chemical complexity of Indigo Blue is defined by a deep, diverse terpene profile. The bouquet is led by the spicy, peppery notes of caryophyllene, followed by the earthy sweetness of myrcene and the bright citrus edge of limonene. These are further nuanced by layers of pinene, humulene, and ocimene, with trace contributions from nerolidol, linalool, beta-pinene, guaiol, p-cymene, bisabolol, eucalyptol, camphene, and caryophyllene-oxide. This broad spectrum of volatile compounds creates a distinct sensory experience that reflects the strain's intricate botanical composition.

As a THC-dominant cultivar, Indigo Blue is primarily utilized for its ability to induce states of relaxation, calm, and mental focus. These therapeutic effects make it a frequent choice for users seeking relief from symptoms of pain and stress, as well as those looking to manage sleep-related challenges. Beyond its immediate physical and cognitive impact, the strain is recognized for its lasting influence on the market through the development of the Oxygen 19 line.